During the past decade, Institut National D'Oncologie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut National D'Oncologie" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Institut National d'Oncologie, Morocco" with 2 trials sponsored, "International Atomic Energy Agency" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Gustave Roussy, Cancer Campus, Grand Paris" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut National D'Oncologie" #1 collaborator was "International Network for Cancer Treatment and Research" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institut National D'Oncologie" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervix Cancer" (1 trials) and "Colon Adenocarcinoma" (1 trials). Many other conditions were trialed in "Institut National D'Oncologie" in a lesser frequency.

Most popular intervention types in "Institut National D'Oncologie" are "Drug" (9 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Docetaxel" (2 trials) and "Radiotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut National D'Oncologie" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Institut National D'Oncologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Institut National D'Oncologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut National D'Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".